Vanguard Personalized Indexing Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.05M Buy
11,414
+1,227
+12% +$123K 0.01% 904
2025
Q4
$1.04M Buy
10,187
+1,207
+13% +$108K 0.01% 895
2025
Q3
$561K Buy
8,980
+718
+9% +$39.1K 0.01% 1197
2025
Q2
$430K Buy
8,262
+1,280
+18% +$57.2K ﹤0.01% 1273
2025
Q1
$297K Buy
+6,982
New +$301K ﹤0.01% 1340
2023
Q1
Sell
-7,848
Closed -$213K 1479
2022
Q4
$213K Sell
7,848
-1,568
-17% -$71.7K 0.01% 1125
2022
Q3
$507K Buy
9,416
+556
+6% +$28.5K 0.02% 780
2022
Q2
$357K Sell
8,860
-5,152
-37% -$255K 0.02% 928
2022
Q1
$928K Buy
+14,012
New +$959K 0.04% 485
2021
Q4
Sell
-4,902
Closed -$613K 1077
2021
Q3
$613K Buy
+4,902
New +$582K 0.06% 419

Other funds holding GH

Vanguard Personalized Indexing Management's GH Position: Q1 2026 in Review

Vanguard Personalized Indexing Management increased its Guardant Health (GH) stake by 12% in Q1 2026, buying an estimated $123K and bringing the position to 11,414 shares worth $1.05M. The position accounts for 0.01% of the portfolio, ranked #904.

Vanguard Personalized Indexing Management first reported a position in GH in Q3 2021 and has held it in 10 quarters since. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Vanguard Personalized Indexing Management held 11,414 shares of Guardant Health worth $1.05M as of Q1 2026.
  • Vanguard Personalized Indexing Management bought 1,227 Guardant Health shares in Q1 2026, an estimated $123K.
  • Guardant Health made up 0.01% of Vanguard Personalized Indexing Management's portfolio in Q1 2026, its #904 holding.
  • Vanguard Personalized Indexing Management first reported a position in Guardant Health in Q3 2021 and has held it in 10 quarters since.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2026, filed 14 May 2026.